OBJECTIVES: To identify and assess the effects of general practitioner and patient characteristics on global adherence to pharmacotherapeutic guidelines. METHODS: In a cross-sectional study in the northern Netherlands, a two-level multilevel model was applied to patients (n = 269,067) in 190 practices with a total of 251 general practitioners. The dependent variable was the global adherence to pharmacotherapeutic guidelines as a measure of good prescribing in a general practice setting. RESULTS: The mean global adherence was 82%. Two general practice variables, organization form and degree of urbanization influenced the global adherence, whereas all patient variables (age and gender) and the patient-related prescription characteristics (costs, volume, different ATC-codes) were significant predictors for the global adherence. The total explained variance was 28%. CONCLUSIONS: Patient characteristics have a greater influence on prescribing behavior than general practitioner characteristics.
OBJECTIVES: To identify and assess the effects of general practitioner and patient characteristics on global adherence to pharmacotherapeutic guidelines. METHODS: In a cross-sectional study in the northern Netherlands, a two-level multilevel model was applied to patients (n = 269,067) in 190 practices with a total of 251 general practitioners. The dependent variable was the global adherence to pharmacotherapeutic guidelines as a measure of good prescribing in a general practice setting. RESULTS: The mean global adherence was 82%. Two general practice variables, organization form and degree of urbanization influenced the global adherence, whereas all patient variables (age and gender) and the patient-related prescription characteristics (costs, volume, different ATC-codes) were significant predictors for the global adherence. The total explained variance was 28%. CONCLUSIONS:Patient characteristics have a greater influence on prescribing behavior than general practitioner characteristics.
Authors: Simone A van Dulmen; Sue Lukersmith; Josephine Muxlow; Elaine Santa Mina; Maria W G Nijhuis-van der Sanden; Philip J van der Wees Journal: Health Expect Date: 2013-10-14 Impact factor: 3.377
Authors: Farifteh Firoozmand Duffy; William Narrow; Joyce C West; Laura J Fochtmann; David A Kahn; Trisha Suppes; John M Oldham; John S McIntyre; Ronald W Manderscheid; Paul Sirovatka; Darrel Regier Journal: Psychiatr Q Date: 2005
Authors: Anna Kotzeva; Ivan Solà; José Miguel Carrasco; Petra Díaz del Campo; Francisco Javier Gracia; Enrique Calderón; Idoia de Gaminde; Maria Dolors Estrada; Flora Martínez; Carola Orrego; Rafael Rotaeche; Flavia Salcedo; Paola Velázquez; Pablo Alonso-Coello Journal: BMC Health Serv Res Date: 2010-12-03 Impact factor: 2.655
Authors: Agnes J Smink; Sita M A Bierma-Zeinstra; Joost Dekker; Thea P M Vliet Vlieland; Johannes W J Bijlsma; Bart A Swierstra; Joke H Kortland; Theo B Voorn; Cornelia H M van den Ende; Henk J Schers Journal: BMC Fam Pract Date: 2013-03-11 Impact factor: 2.497